Bessemer Group’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-44,100
Closed -$597K 1642
2020
Q2
$597K Buy
+44,100
New +$597K ﹤0.01% 923